Histopathologic Analysis of Surgically Resected Lungs of Patients with Non-tuberculous Mycobacterial Lung Disease: a Retrospective and Hypothesis-generating Study
- PMID: 34970090
- PMCID: PMC8686772
Histopathologic Analysis of Surgically Resected Lungs of Patients with Non-tuberculous Mycobacterial Lung Disease: a Retrospective and Hypothesis-generating Study
Abstract
Non-tuberculous mycobacterial lung disease (NTM-LD) is most commonly due to species within the Mycobacterium avium complex (MAC) and Mycobacterium abscessus complex (MAbC). Surgical lung resection, typically a lobectomy or segmentectomy, is occasionally undertaken for individuals with recalcitrant but localized NTM-LD. Since the growth characteristics of MAC (slow growers) and MAbC (rapid growers) as well as their drug susceptibility patterns are significantly different, the objective of this study is to characterize and compare the histopathologic features of the resected lungs due to these two major NTM groups. From 1996 to 2017, 356 patients with NTM-LD due to MAC (n=270), MAbC (n=54), or both (n=32) underwent a total of 404 lobar resections (with the lingula counted as a separate lobe) at the University of Colorado Hospital. We analyzed by microscopy the existing surgical lung tissue sections for bronchiolitis, bronchiolectasis, bronchiectasis, non-necrotizing granuloma (airway, parenchymal, and total), necrotizing granuloma (airway, parenchymal, and total), peri-airway fibrosis, fibrous pleuritis, and lymphoid follicles. There were no significant differences in the presence or absence of most of the histopathologic features of surgically removed lungs due to MAC, MAbC, or both MAC + MAbC. However, there were significantly more necrotizing granulomas (airway, parenchymal, and total) and fibrous pleuritis in MAC compared to MAbC lung diseases. Since necrotizing granulomas may be a sign of inadequate control of the infection, we posit that their presence may be an indication of increased chronicity, increased virulence of MAC compared to MAbC, and/or impaired host immunity against the NTM. Futures studies to determine the root cause of such differences in histopathologic findings in MAC versus MAbC lung disease may spawn new leads on differential pathogenic mechanisms with different NTM, with the goal of aiming for more targeted therapy against both the NTM and the lung damage induced by them.
Keywords: granulomas; histopathology; lung disease; mycobacteria; pathology.
Copyright ©2021, Yale Journal of Biology and Medicine.
Figures

Similar articles
-
Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.Antimicrob Agents Chemother. 2018 Sep 24;62(10):e01105-18. doi: 10.1128/AAC.01105-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30104265 Free PMC article.
-
Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.PLoS One. 2022 Mar 24;17(3):e0265358. doi: 10.1371/journal.pone.0265358. eCollection 2022. PLoS One. 2022. PMID: 35324922 Free PMC article.
-
Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.Respir Med. 2017 Dec;133:36-41. doi: 10.1016/j.rmed.2017.11.005. Epub 2017 Nov 6. Respir Med. 2017. PMID: 29173447
-
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.J Korean Med Sci. 2016 May;31(5):649-59. doi: 10.3346/jkms.2016.31.5.649. Epub 2016 Mar 22. J Korean Med Sci. 2016. PMID: 27134484 Free PMC article. Review.
-
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8. Respir Med. 2019. PMID: 31128614 Review.
Cited by
-
C3HeB/FeJ mice with chronic Mycobacterium avium complex pulmonary infection exhibit impaired respiratory function but not necrotising granulomatous disease.Mycobacteria. 2025;1(1):4. doi: 10.1186/s44350-025-00004-7. Epub 2025 May 15. Mycobacteria. 2025. PMID: 40386578 Free PMC article.
-
Comparative analysis of non-tuberculous mycobacterial lung disease and lung colonization: a case-control study.BMC Infect Dis. 2024 Oct 15;24(1):1159. doi: 10.1186/s12879-024-10067-y. BMC Infect Dis. 2024. PMID: 39407161 Free PMC article.
-
T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren.Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0053622. doi: 10.1128/aac.00536-22. Epub 2022 May 31. Antimicrob Agents Chemother. 2022. PMID: 35638855 Free PMC article.
-
Biotin-dependent cell envelope remodelling is required for Mycobacterium abscessus survival in lung infection.Nat Microbiol. 2023 Mar;8(3):481-497. doi: 10.1038/s41564-022-01307-5. Epub 2023 Jan 19. Nat Microbiol. 2023. PMID: 36658396 Free PMC article.
-
Lymphocyte-Directed Immunomodulation Remits Thymoma-Associated Autoimmune Pneumonitis.J Clin Immunol. 2024 Jul 1;44(7):156. doi: 10.1007/s10875-024-01760-3. J Clin Immunol. 2024. PMID: 38954150 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials